AarogyaAI is an artificial intelligence-based software as a service that diagnoses drug-resistant tuberculosis. AarogyaAI uses a DNA sequence from the patient which is uploaded to SaaS. Its machine-learning algorithm then gives an output report of a comprehensive drug susceptibility status of the patient.
AccuRx is on a mission to bring patients and their healthcare teams together. We let GP practices communicate with their patients, team and other organisations. In a year we’ve grown from being used in 10 GP practices, to 20% of GP practices in England.
Affable is building an end-to-end platform that brings intelligence and automation to influencer marketing. They derive insights about micro influencers and their audience by using cutting edge computer vision algorithms on social media posts. Affable is building the technology that enables one-click influencer marketing at scale, doing to social what Google Adwords did to search.
Ai Palette is world’s first Artificial Intelligence platform for FMCG Product Innovation. Ai Palette creates winning product concepts in line with a brand’s personality & its existing product portfolio. It does this by garnering insights from millions of digital conversations and coupling them with the company data to create product concepts which addresses the unmet needs of consumers.
Airbank is the next-generation financial management platform for startups and small and medium-sized businesses (SMBs). Airbank transforms B2B finance for SMBs in Europe by building the simplest way for businesses to collect, pay, and finance invoices. Airbank connects with existing bank accounts of its users and provides real-time visibility into their cash flow.
Airboxr helps non-technical business users make data-driven decisions without leaning on developers and business intelligence analysts—especially for organizations with no data infrastructure and lack of BI capabilities. Airboxr is a no-code query and enrichment tool for faster decision-making. It works right within spreadsheets and enables non-technical users to work with live data across data sources.
Concrete is the most widely used building material on our planet. The only thing mankind uses more of is water. With a wave of urban development coming in the next few decades, concrete is also a rapidly growing trillion-dollar market. However, cement and concrete production is responsible for 8% of the global CO2 emissions, making its growth a big cause for concern. Low-carbon concrete exists - but until now it has been too sophisticated to be produced reliably and on a large scale. It contains very little burnt limestone - responsible for the strength of concrete and CO2 emissions. This makes low-carbon concrete vulnerable to fluctuations in raw materials and operating conditions and thus difficult to produce with reliable quality. Adding to the challenge: the final quality of concrete can only be measured weeks AFTER it has been processed on the construction site - far too late to be corrected. This is why our world is still built on more robust, high-carbon concrete. Using alcemy's software, cement and concrete producers receive precise quality predictions already during production. Based on these prediction models, our AI identifies which production parameters need to be adjusted to mitigate the impact of fluctuations. Thus, the quality of cement and concrete can be optimized BEFORE delivery – for the first time in history. The result is significantly more consistent product quality, allowing producers to safely replace burnt limestone with less expensive, low-carbon materials found in nature. In this way, they can also avoid payments for CO2 emission certificates in the EU. Saving costs, bringing production processes up to speed for 21st century concrete recipes, and saving half of Europe’s CO2 emissions goes hand in hand at alcemy. Join us on our journey to make low-carbon concrete a reality!
Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzyme development to the next level.
Amber is building an electricity future that actually works for customers. Amber uses real-time wholesale pricing to help customers use cheap renewables when they are produced – saving money for customers and bringing more renewables online. The rapid influx of renewable electricity is completely changing the economics and dynamics of the grid system. To let customers benefit from this change, we need to make them equal participants in the market, rather than an afterthought.